{"gene":"MLLT1","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":1994,"finding":"ENL (MLLT1) is a nuclear protein with transcriptional transactivation activity in both lymphoid and myeloid cells, and in yeast. Deletion mutagenesis localized the minimal transcriptional activation domain to the C-terminal 90 amino acids of ENL, a region highly conserved with AF9 that is retained in all HRX-ENL and HRX-AF9 fusion proteins.","method":"Deletion mutagenesis, transient reporter gene assays in lymphoid and myeloid cell lines and yeast","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct mutagenesis with functional reporter assays, replicated across multiple cell types including yeast","pmids":["8080983"],"is_preprint":false},{"year":1998,"finding":"The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity contributed by the C-terminal 84 amino acids of ENL (encoding two conserved helical structures). Deletions of either helix completely abrogated both transcriptional activation and in vitro myeloid transforming activity. The MLL methyltransferase homology domain was shown to bind DNA non-sequence specifically in vitro.","method":"Structure-function deletion analysis, in vitro myeloid immortalization assay, transcriptional reporter assays, in vitro DNA binding assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis coupled with both transformation and transcription assays; directly correlates ENL C-terminal domain function with leukemogenic activity","pmids":["9418860"],"is_preprint":false},{"year":1997,"finding":"HRX-ENL fusion protein directly immortalizes a myelomonocytic precursor and induces myeloid leukemia in mice. Wild-type ENL alone or HRX-ENL lacking the ENL component did not transform cells, establishing that the ENL moiety is required for the gain-of-function leukemogenic activity.","method":"Retroviral transduction of hematopoietic stem cells, serial replating colony assay, syngeneic and SCID mouse leukemia model","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — deletion mutant controls in both in vitro and in vivo transformation assays; replicated across multiple recipient mouse strains","pmids":["9250666"],"is_preprint":false},{"year":2001,"finding":"The C-terminal domain of ENL (the same region required for transformation) directly recruits human Polycomb 3 (hPc3/CBX8) via a protein-protein interaction. This was demonstrated by yeast two-hybrid, GST pull-down, far-western blot, mutual co-immunoprecipitation from cell extracts, and co-localization of fluorescently tagged proteins in nuclear dot patterns in living cells.","method":"Yeast two-hybrid, GST pull-down, far-western blot, co-immunoprecipitation, live-cell fluorescence co-localization","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical methods (Y2H, pulldown, far-western, co-IP, live imaging) all confirming the same interaction","pmids":["11313972"],"is_preprint":false},{"year":2005,"finding":"ENL directly interacts with AF4 and AF5q31 (and a fragment of AF10) through its C-terminus (also the transformation-essential domain). The ENL/AF4 interaction was confirmed by GST pull-down and mutual co-immunoprecipitation. Both proteins co-localized in nuclear speckles in vivo and co-eluted on sizing columns with Polycomb3, suggesting a multiprotein complex. The YEATS domain of ENL is essential for transcriptional activation from a reporter construct. ENL binds histones H3 and H1 in a YEATS domain-dependent manner.","method":"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, co-localization, size exclusion chromatography, histone overlay and pull-down assays, reporter assay with YEATS domain mutants","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods confirming interactions and YEATS domain function; YEATS-dependent histone binding established by overlay/pulldown with mutagenesis","pmids":["15856011"],"is_preprint":false},{"year":2007,"finding":"ENL associates in vivo with a complex (EAP) containing pTEFb (CDK9/Cyclin T), DOT1L (histone H3K79 methyltransferase), AF4, AF5q31, LAF4, and Polycomb members (RING1, CBX8, BCoR). Purified EAP displayed H3K79-specific methylase activity and robust RNA Pol II CTD kinase function. ENL knockdown reduced genome-wide H3K79 dimethylation and global transcriptional elongation. DOT1L recruitment to ENL was important for transformation by MLL-ENL.","method":"Immunopurification + mass spectrometry, co-immunoprecipitation, yeast two-hybrid, GST pull-down, co-localization, in vitro histone methylase assay, RNA Pol II CTD kinase assay, global run-on elongation assay, shRNA knockdown","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (IP-MS, co-IP, in vitro enzymatic assays, knockdown phenotypes) in single study; mechanistically links ENL to elongation and H3K79 methylation","pmids":["17855633"],"is_preprint":false},{"year":2010,"finding":"ENL and AF9 family proteins together with AF4 family proteins form a higher-order complex (AEP) containing P-TEFb. AEP is normally recruited to MLL-target chromatin to facilitate transcription, and MLL oncoproteins fused with AEP components constitutively form hybrid complexes causing sustained target gene expression and hematopoietic progenitor transformation.","method":"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), hematopoietic progenitor transformation assay","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP and ChIP establish complex formation and chromatin recruitment; transformation assays demonstrate functional consequence","pmids":["20153263"],"is_preprint":false},{"year":2015,"finding":"In response to DNA double-strand breaks (DSBs), ENL is phosphorylated by ATM at conserved SQ sites. This phosphorylation increases ENL's interaction with PRC1 via BMI1, promoting enrichment of PRC1 at transcription elongation sites near DSBs, leading to H2A ubiquitination and transcriptional repression. ENL SQ sites and BMI1 are required for KU70 accumulation at DSBs near active transcription.","method":"Co-immunoprecipitation, phosphorylation assays, ChIP, siRNA knockdown, DSB survival assays, ATM kinase assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods establishing ATM-dependent phosphorylation of ENL and its functional consequence in transcriptional repression at DSBs","pmids":["25921070"],"is_preprint":false},{"year":2017,"finding":"The YEATS chromatin-reader domain of ENL is essential for ENL-dependent leukaemic growth. Acute loss of ENL (via chemical genetic targeted degradation) suppressed initiation and elongation of RNA polymerase II at active genes genome-wide, with pronounced effects at genes with disproportionate ENL load. CRISPR loss-of-function screen identified ENL as specifically required for proliferation in MLL-AF4-positive leukemia in vitro and in vivo.","method":"CRISPR-Cas9 genome-scale loss-of-function screen, auxin-inducible degron targeted protein degradation, ChIP-seq, RNA Pol II elongation assays, YEATS domain point mutagenesis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genome-scale genetic screen combined with targeted protein degradation, functional mutagenesis of YEATS domain, and genome-wide mechanistic assays in single rigorous study","pmids":["28241139"],"is_preprint":false},{"year":2015,"finding":"Recurrent gain-of-function mutations in the YEATS domain of MLLT1 (ENL) in Wilms tumours alter binding to acetylated histone tails. Mutant MLLT1 tumours show increased MYC expression and HOX dysregulation.","method":"Genomic sequencing of Wilms tumour samples, biochemical binding assays of mutant vs wild-type YEATS domain to acetylated histone tails, gene expression analysis","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct biochemical demonstration of altered acetyl-histone binding by YEATS mutants; functional consequence inferred from gene expression; single study","pmids":["26635203"],"is_preprint":false},{"year":2022,"finding":"Cancer-associated hotspot mutations in the ENL YEATS domain trigger aberrant transcriptional condensates at native genomic targets. Mechanistically, mutation-induced structural changes in the YEATS domain, ENL's two disordered regions of opposing charges, and incorporation of extrinsic elongation factors are all required for condensate formation. Extensive mutagenesis establishes condensate formation as a driver of oncogenic gene activation.","method":"Fluorescence live-cell imaging, FRAP, mutagenesis, ChIP-seq, gene expression analysis, structural analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — extensive mutagenesis, live-cell imaging with FRAP, and ChIP-seq mechanistically link mutation-induced condensate formation to oncogenic transcription","pmids":["36272410"],"is_preprint":false},{"year":2020,"finding":"ENL, or its intrinsically disordered region (IDR) alone, is sufficient to initiate liquid-liquid phase separation and liquid droplet formation of the super elongation complex (SEC). AFF4 cooperates with ENL in fluidizing SEC droplets. SEC droplets form rapidly upon serum exposure and are required for rapid transcriptional induction. MLL-ENL fusion boosts SEC phase separation compared to wild-type ENL.","method":"In vitro droplet formation assays, live-cell fluorescence imaging, FRAP, transcriptional reporter assays, IDR deletion/mutagenesis","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro reconstitution of phase separation, live-cell imaging with FRAP, and functional mutagenesis of IDR in single study","pmids":["32270036"],"is_preprint":false},{"year":2013,"finding":"ENL serves as a scaffold that contacts the elongation machinery AND Polycomb repressive complex 1 (PRC1) component CBX8, but these interactions are mutually exclusive in vitro. CBX8 inhibits transcriptional elongation in a reporter assay, and this is neutralized by direct ENL-CBX8 association. CBX8-binding-defective MLL-ENL cannot fully activate leukemogenic gene loci. MLL-ENL also dimerizes as a neomorphic activity that may augment Polycomb inhibition.","method":"Biochemical co-immunoprecipitation, in vitro binding (mutual exclusivity), transcriptional reporter assay, mutagenesis, transformation assay in hematopoietic progenitors","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro mutual exclusivity of interactions established biochemically, corroborated by in vivo transformation assays with structure-function mutants","pmids":["23623499"],"is_preprint":false},{"year":2000,"finding":"ENL directly interacts with ABI1 (c-Abl interactor 1, itself fused to MLL in t(10;11) leukemia). Identified by yeast two-hybrid screen; verified by far-western blot, GST pull-down, and co-immunoprecipitation from cell extracts. Structure-function analysis identified an internal region of ENL and a composite SH3-containing motif of ABI1 as mutual binding partners.","method":"Yeast two-hybrid, far-western blot, GST pull-down, co-immunoprecipitation, deletion mapping","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical methods (Y2H, far-western, GST pulldown, co-IP) with domain mapping","pmids":["10777208"],"is_preprint":false},{"year":2008,"finding":"Insertion of the third PHD finger of MLL into MLL-ENL allows recruitment of Cyp33 and subsequently HDAC1 to the fusion protein, mediates HOX gene downregulation in a Cyp33-dependent manner, and blocks hematopoietic stem cell immortalization by MLL-ENL. Loss of the PHD fingers in MLL fusion proteins is thus necessary for the constitutive transactivation that drives leukemogenesis.","method":"Co-immunoprecipitation, gene expression analysis (RT-PCR), serial replating colony assay (immortalization), domain insertion mutagenesis","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain insertion mutagenesis with co-IP and functional immortalization assay; single laboratory study with clear mechanistic conclusion","pmids":["18676843"],"is_preprint":false},{"year":2014,"finding":"A specific salt bridge formed by a pair of amino acids between MLLT1/ENL and AFF family proteins (AF4/AFF1) is critically important for MLL-ENL-mediated transformation of hematopoietic progenitor cells. Mutational disruption of this salt bridge abrogates transformation.","method":"Mutational analysis, hematopoietic progenitor cell transformation assay, structural modeling informed by MLLT3-AFF1 complex structure","journal":"Leukemia research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — structure-guided mutagenesis with functional transformation assay; single lab, informed by structural data from paralog","pmids":["25282333"],"is_preprint":false},{"year":2022,"finding":"ENL YEATS domain displaces from chromatin upon treatment with the small-molecule inhibitor TDI-11055 (blocking acylated histone interaction), rapidly decreasing chromatin occupancy of ENL-associated complexes and impairing transcription elongation, leading to suppression of oncogenic gene programs and induction of differentiation. A CRISPR-Cas9 mutagenesis screen identified an ENL mutation conferring resistance, validating on-target chromatin displacement mechanism.","method":"ChIP-seq, RNA-seq, CRISPR resistance screen, patient-derived xenograft in vivo model, biochemical YEATS domain binding assay","journal":"Cancer discovery","confidence":"High","confidence_rationale":"Tier 2 / Strong — on-target validation by resistance mutagenesis, genome-wide chromatin displacement shown by ChIP-seq, in vivo efficacy, multiple orthogonal methods","pmids":["36053276"],"is_preprint":false},{"year":2022,"finding":"KAT6A-catalyzed H3K9 acetylation at promoters is bound by the ENL YEATS domain, initiating a transcriptional control module in which ENL cooperates with a network of chromatin factors to induce transcriptional elongation. KAT6A inhibition phenocopies ENL loss in AML.","method":"CRISPR differentiation screen, co-immunoprecipitation, ChIP-seq, KAT6A inhibition, ENL YEATS domain binding assays","journal":"Cancer discovery","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR screen combined with co-IP, ChIP-seq, and biochemical YEATS-acetylH3K9 interaction established mechanistic writer-reader module","pmids":["34853079"],"is_preprint":false},{"year":2024,"finding":"ENL YEATS domain binds histone H3K9β-hydroxybutyrylation (H3K9bhb), a new histone acyl mark. Chemical proteomics with multivalent photoaffinity probes identified ENL as a novel H3K9bhb reader. CUT&Tag confirmed co-localization of ENL with H3K9bhb at promoters. Structure-based mutation disrupting H3K9bhb-ENL interaction suppressed MYC-driven cell proliferation.","method":"Chemical proteomics (photoaffinity probes), biochemical binding assay, CUT&Tag chromatin profiling, structure-based mutagenesis, gene expression analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — chemical proteomics discovery confirmed by biochemical binding, chromatin localization, and functional structure-based mutagenesis in single study","pmids":["38880495"],"is_preprint":false},{"year":2025,"finding":"ENL associates with the acetyltransferase MOZ through a multivalent assembly. The extraterminal (ET) domain of ENL recognizes the canonical ET-binding motif in the intrinsically disordered region (IDR) of MOZ. Additionally, the YEATS domain of ENL binds to acetylation sites within the MOZ IDR that are generated by CBP/p300 acetyltransferase activity. Genomic analysis showed ENL and MOZ co-occupy active promoters, and MOZ recruits ENL to its gene targets.","method":"Structural studies, co-immunoprecipitation, ChIP-seq, domain mutagenesis, biochemical binding assays","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — structural resolution of multivalent assembly combined with functional genomics and mutagenesis confirming acetylation-dependent and -independent ENL-MOZ coupling","pmids":["39794553"],"is_preprint":false},{"year":2001,"finding":"MLL-ENL-induced block of myelomonocytic cell differentiation requires the oncoprotein Myc. Co-transduction of dominant-negative Myc neutralized MLL-ENL transformation, while constitutive Myc expression cooperated with MLL-ENL to cause irreversible maturation arrest. G-CSF-mediated differentiation was accompanied by c-myc downregulation.","method":"Retroviral co-transduction, dominant-negative Myc expression, gene expression analysis, colony assay, differentiation assay with G-CSF","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis via dominant-negative and overexpression approaches in primary hematopoietic cells; single lab study","pmids":["11522644"],"is_preprint":false},{"year":2004,"finding":"MLL-ENL activates Hoxa9, Hoxa7, Meis1, and Pbx3 expression as critical downstream targets. Enforced expression of Hoxa9 combined with Meis1 was sufficient to substitute for MLL-ENL function and maintain continuous proliferation and differentiation arrest. Overexpression of the Hox repressor Bmi-1 inhibited MLL-ENL growth-transforming activity.","method":"Inducible MLL-ENL-ERtm system, microarray analysis, retroviral overexpression, tamoxifen withdrawal differentiation assay, Bmi-1 overexpression epistasis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible system combined with target identification, epistasis (Bmi-1), and rescue (Hoxa9+Meis1) experiments establishing pathway hierarchy","pmids":["14701735"],"is_preprint":false},{"year":2016,"finding":"MLL-ENL directly targets two functionally distinct gene groups: ME5 genes bound at promoters, dependent on DOT1L-mediated H3K79 methylation, encoding transcription factors including Hox genes; and ME3 genes with MLL-ENL accumulation beyond the termination site, dependent on P-TEFb-mediated RNA Pol II phosphorylation, encoding proteins in RNA biology and ribosome assembly. These groups show differential sensitivity to DOT1L and P-TEFb inhibitors.","method":"Nascent RNA-seq, ChIP-seq, small molecule inhibitor treatment (DOT1L and P-TEFb inhibitors), transformed cell line analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide nascent RNA and chromatin profiling combined with pharmacological inhibition distinguishing two mechanistically distinct MLL-ENL target gene classes","pmids":["27050521"],"is_preprint":false},{"year":2022,"finding":"The YEATS domain within the MLL-ENL fusion protein is retained in 84.1% of MLL-ENL patient samples and is crucial for MLL-ENL-mediated leukemogenesis in mouse models. Deletion of the YEATS domain impaired MLL-ENL binding and decreased expression of pro-leukemic genes including Eya1 and Meis1. Point mutations disrupting YEATS domain binding to acetylated histones decreased leukemic stem cell frequency and increased leukemia latency.","method":"Retroviral mouse leukemia model, YEATS domain deletion and point mutagenesis, ChIP, gene expression analysis, limiting dilution transplantation for stem cell frequency","journal":"Leukemia","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain deletion and point mutagenesis with in vivo leukemia models and stem cell frequency assays; corroborated by patient sample analysis","pmids":["36435883"],"is_preprint":false},{"year":2021,"finding":"SIRT2 deacetylase regulates MLL-ENL-driven AML. A conserved lysine K469 in the ENL linker region controls cell cycle progression and chemotherapy resistance; substitution with an acetylated mimic (K469Q) abolished MLL-ENL's ability to suppress proliferation and promote chemo-resistance. SIRT2 deletion promoted proliferation and sensitized MLL-ENL AML cells to chemotherapy.","method":"Murine MLL-ENL AML model, K469Q acetylation mimic mutagenesis, Sirt2 knockout, cell cycle analysis, chemotherapy sensitivity assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — acetylation mimic mutagenesis and Sirt2 KO with functional read-outs; single lab, focused on ENL linker region acetylation","pmids":["35108652"],"is_preprint":false},{"year":2021,"finding":"The intrinsically disordered C-terminal ANC1 homology domain (AHD) of ENL/MLLT1 undergoes coupled binding and folding upon interaction with partner proteins including AF4, DOT1L, BCOR, and CBX8. NMR backbone dynamics studies of the complexes revealed dynamics-dependent function of the AHD.","method":"NMR spectroscopy, binding assays, structural analysis of AHD complexes","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — NMR-based structural characterization; review article summarizing structural work, but reports direct NMR/structural findings; single consolidated description","pmids":["34174329"],"is_preprint":false},{"year":2024,"finding":"ENL occupies the majority of super-enhancers (SEs) with higher preference over typical enhancers in a manner dependent on its ability to bind acetylated histones (YEATS domain). Rapid ENL depletion decommissions SEs, repressing SE-controlled oncogenes such as MYC. ENL interacts with the histone chaperone FACT complex and is required for FACT deposition over cis-regulatory elements; ENL's transcriptional control is regulated by BRD4.","method":"Auxin-inducible degron (AID) rapid depletion, ChIP-seq, FACT co-immunoprecipitation, ENL YEATS mutants, BRD4 inhibition, colorectal cancer in vivo model","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — rapid protein depletion with genome-wide ChIP-seq, co-IP for FACT interaction, and YEATS mutant studies establish SE regulation and FACT recruitment as direct ENL functions","pmids":["38241700"],"is_preprint":false},{"year":2002,"finding":"Targeted disruption of murine Mllt1 leads to embryonic lethality prior to embryonic day 8.5, indicating an essential role for MLLT1 in early embryonic development.","method":"Gene targeting/knockout in mice, developmental phenotype analysis","journal":"Blood cells, molecules & diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout with defined embryonic lethal phenotype; single study establishing developmental essentiality","pmids":["12367585"],"is_preprint":false},{"year":2024,"finding":"In Drosophila, pan-neuronal knockdown of dENL/AF9 (the ENL/AF9 ortholog) extends lifespan and enhances fitness during aging, including improved sleep and locomotion. This is associated with upregulation of catalase, reduced malondialdehyde, and enhanced oxidative stress tolerance, revealing a role for the histone acylation (crotonylation) reader function of ENL/AF9 in neuronal aging.","method":"Pan-neuronal RNAi knockdown in Drosophila, lifespan analysis, locomotion assays, sleep analysis, oxidative stress assays, gene expression analysis","journal":"Neurobiology of aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo knockdown in Drosophila with multiple functional readouts; ortholog study with clear link to crotonylation reader function in aging","pmids":["39405796"],"is_preprint":false}],"current_model":"MLLT1/ENL is a nuclear transcriptional coactivator containing an N-terminal YEATS domain that reads acetylated (and other acylated) histone lysines (particularly H3K9ac, H3K9cr, H3K9bhb) to recruit RNA Pol II elongation machinery, and a C-terminal intrinsically disordered ANC1 homology domain (AHD) that scaffolds a higher-order complex (AEP/SEC) with AF4 family proteins, P-TEFb, and DOT1L, driving transcriptional elongation and H3K79 methylation at target genes; upon DNA double-strand breaks, ENL is phosphorylated by ATM, switching its interaction from the elongation complex to PRC1 (via BMI1) to repress transcription near damage sites; gain-of-function YEATS mutations drive aberrant phase-separated condensates and oncogenic gene activation, while the MLL-ENL fusion constitutively recruits AEP to MLL target genes (Hoxa cluster, Meis1, Myc) to immortalize hematopoietic progenitors and cause leukemia."},"narrative":{"mechanistic_narrative":"MLLT1/ENL is a nuclear transcriptional coactivator that couples histone acylation recognition to RNA polymerase II elongation at active genes and super-enhancers [PMID:28241139, PMID:38241700]. Its N-terminal YEATS domain reads acetylated and other acylated histone lysines—including KAT6A/MOZ-deposited H3K9ac and the ketone-body mark H3K9β-hydroxybutyrylation—and this reader activity recruits ENL-associated complexes to chromatin to drive elongation [PMID:34853079, PMID:38880495, PMID:39794553]. Through its C-terminal intrinsically disordered ANC1 homology domain (AHD), ENL scaffolds a higher-order elongation assembly (EAP/AEP/SEC) by coupled folding upon binding AF4-family proteins, P-TEFb (CDK9/Cyclin T), and the H3K79 methyltransferase DOT1L, and ENL is required for genome-wide H3K79 dimethylation and transcriptional elongation [PMID:17855633, PMID:20153263, PMID:34174329]. The same domain alternatively engages PRC1 component CBX8, and these elongation- versus repression-directed interactions are mutually exclusive, allowing ENL to switch between activating and silencing outputs [PMID:11313972, PMID:23623499]. Following DNA double-strand breaks, ATM phosphorylates ENL at SQ sites, shifting it toward PRC1/BMI1 to promote local H2A ubiquitination and transcriptional repression near damage [PMID:25921070]. ENL's intrinsically disordered regions drive liquid-liquid phase separation that fluidizes elongation-complex condensates required for rapid transcriptional induction [PMID:32270036]. In disease, the MLL-ENL fusion constitutively recruits this elongation machinery to MLL targets (Hoxa cluster, Meis1, Myc) to immortalize hematopoietic progenitors and cause leukemia in a YEATS- and AF4-interaction-dependent manner [PMID:9250666, PMID:14701735, PMID:36435883], and recurrent gain-of-function YEATS mutations in Wilms tumour generate aberrant transcriptional condensates that activate MYC and HOX programs [PMID:26635203, PMID:36272410]. ENL is genetically essential in MLL-rearranged leukemia and is a validated drug target via YEATS-domain inhibitors that displace it from chromatin [PMID:28241139, PMID:36053276].","teleology":[{"year":1994,"claim":"Establishing that ENL is itself a transcriptional activator was the first step toward explaining why its fusion partner matters in leukemia; this localized the activity to a conserved C-terminal domain shared with AF9.","evidence":"Deletion mutagenesis with transient reporter assays in lymphoid, myeloid, and yeast cells","pmids":["8080983"],"confidence":"High","gaps":["No molecular mechanism for activation identified","No interacting partners defined"]},{"year":1997,"claim":"Demonstrating that the ENL moiety is required for HRX-ENL leukemogenesis tied ENL's intrinsic transactivation function directly to oncogenic gain-of-function rather than mere fusion.","evidence":"Retroviral HSC transduction with serial replating and mouse leukemia models using deletion controls","pmids":["9250666"],"confidence":"High","gaps":["Downstream target genes not identified","Molecular partners of the ENL domain unknown"]},{"year":1998,"claim":"Mapping the transforming activity to two C-terminal helices showed that the same domain governs transcription and transformation, defining a single critical functional module.","evidence":"Structure-function deletion analysis with transformation and reporter assays plus in vitro DNA binding","pmids":["9418860"],"confidence":"High","gaps":["Did not identify the proteins recruited by the helices","Non-specific DNA binding role unclear"]},{"year":2000,"claim":"Identifying ABI1 as a direct ENL partner connected ENL to another MLL fusion partner, hinting at a shared interaction network.","evidence":"Yeast two-hybrid, far-western, GST pull-down, co-IP with deletion mapping","pmids":["10777208"],"confidence":"High","gaps":["Functional significance of ENL-ABI1 in transformation untested","Region distinct from the transformation domain"]},{"year":2001,"claim":"Two studies framed ENL as both a Polycomb-linked scaffold and a Myc-dependent transforming agent, foreshadowing its dual repressive/activating roles and downstream effectors.","evidence":"Co-IP/Y2H/far-western for CBX8 interaction; dominant-negative Myc and overexpression epistasis in primary hematopoietic cells","pmids":["11313972","11522644"],"confidence":"High","gaps":["How a Polycomb-binding protein activates transcription unresolved","Direct vs indirect role of Myc unclear"]},{"year":2004,"claim":"Defining Hoxa9/Hoxa7/Meis1/Pbx3 as critical MLL-ENL targets and showing Hoxa9+Meis1 substitutes for the fusion established the downstream transcriptional program driving transformation.","evidence":"Inducible MLL-ENL-ER system with microarray, rescue, and Bmi-1 epistasis","pmids":["14701735"],"confidence":"High","gaps":["Mechanism of target gene selection not defined","How ENL sustains activation unknown"]},{"year":2005,"claim":"Showing ENL binds AF4/AF5q31 through its transformation domain and binds histones via the YEATS domain unified the scaffolding and chromatin-reading functions into one model.","evidence":"Y2H, GST pull-down, co-IP, size exclusion, histone overlay/pulldown, YEATS mutant reporters","pmids":["15856011"],"confidence":"High","gaps":["Specific acyl marks read by YEATS not defined","Composition of full complex incomplete"]},{"year":2007,"claim":"Purifying the EAP complex containing P-TEFb and DOT1L, and showing ENL knockdown reduces global H3K79me2 and elongation, established ENL as a hub linking acylation reading to elongation and H3K79 methylation.","evidence":"IP-MS, co-IP, in vitro methylase/CTD kinase assays, run-on elongation, shRNA","pmids":["17855633"],"confidence":"High","gaps":["Recruitment cues to specific genes not defined","Stoichiometry/architecture of complex unresolved"]},{"year":2008,"claim":"Demonstrating that re-inserting the MLL PHD finger recruits Cyp33/HDAC1 and blocks immortalization clarified that loss of repressive modules is what licenses constitutive MLL-ENL activation.","evidence":"Domain insertion mutagenesis, co-IP, RT-PCR, serial replating","pmids":["18676843"],"confidence":"Medium","gaps":["Single-lab domain-insertion model","Generalizability across MLL fusions untested"]},{"year":2010,"claim":"Defining the AEP higher-order complex and its constitutive hijacking by MLL fusions formalized the mechanistic basis of sustained MLL-target expression and transformation.","evidence":"Reciprocal co-IP, ChIP, hematopoietic transformation assays","pmids":["20153263"],"confidence":"High","gaps":["Dynamics of AEP assembly on chromatin not resolved","Distinction from physiological recruitment unclear"]},{"year":2013,"claim":"Showing ENL's elongation and CBX8/PRC1 contacts are mutually exclusive provided a molecular switch explaining how a single scaffold toggles between activation and Polycomb repression.","evidence":"Co-IP, in vitro mutual-exclusivity binding, reporter assays, transformation with structure-function mutants","pmids":["23623499"],"confidence":"High","gaps":["Trigger that selects between states in vivo unclear","Role of MLL-ENL dimerization not fully resolved"]},{"year":2014,"claim":"Pinpointing a specific ENL-AFF1 salt bridge as essential for transformation provided an atomic-level target within the leukemogenic interaction.","evidence":"Structure-guided mutagenesis and hematopoietic transformation assay","pmids":["25282333"],"confidence":"Medium","gaps":["Modeled from paralog structure, not direct ENL structure","Single-lab validation"]},{"year":2015,"claim":"Two studies extended ENL beyond elongation: ATM phosphorylation switches it to PRC1/BMI1-mediated repression at DSBs, while recurrent Wilms tumour YEATS mutations alter acetyl-histone binding to dysregulate MYC/HOX.","evidence":"Co-IP/phospho/ChIP/ATM assays for DSB response; tumour sequencing and YEATS binding/expression assays for Wilms mutants","pmids":["25921070","26635203"],"confidence":"High","gaps":["Functional consequence of Wilms mutants inferred from expression in single study","How the DSB switch is reversed unknown"]},{"year":2016,"claim":"Resolving MLL-ENL targets into DOT1L-dependent promoter-bound (ME5) and P-TEFb-dependent readthrough (ME3) classes revealed mechanistically distinct gene programs with differential drug sensitivities.","evidence":"Nascent RNA-seq, ChIP-seq, and DOT1L/P-TEFb inhibitor treatment","pmids":["27050521"],"confidence":"High","gaps":["Determinants of class assignment unclear","Applicability to wild-type ENL targets untested"]},{"year":2017,"claim":"A genome-scale CRISPR screen plus targeted degradation established ENL as a non-redundant, YEATS-dependent dependency controlling Pol II initiation and elongation in MLL-AF4 leukemia.","evidence":"CRISPR LOF screen, auxin-inducible degron, ChIP-seq, YEATS point mutants","pmids":["28241139"],"confidence":"High","gaps":["Mechanism distinguishing high-load genes unresolved","Physiological (non-leukemic) requirement less defined"]},{"year":2020,"claim":"Demonstrating that ENL's IDR drives phase separation of the SEC introduced condensate formation as the physical basis for rapid transcriptional induction and MLL-ENL enhancement.","evidence":"In vitro droplet assays, live-cell imaging, FRAP, IDR mutagenesis, reporters","pmids":["32270036"],"confidence":"High","gaps":["Endogenous-level condensate relevance at native loci not fully shown","Contribution to gene specificity unclear"]},{"year":2021,"claim":"Structural and regulatory studies refined ENL function: the AHD folds upon binding diverse partners, and SIRT2-controlled K469 acetylation in the linker modulates MLL-ENL proliferation and chemoresistance.","evidence":"NMR backbone dynamics of AHD complexes; K469Q mimic and Sirt2 KO in murine AML","pmids":["34174329","35108652"],"confidence":"Medium","gaps":["AHD findings consolidated/review-level","SIRT2-ENL axis from single lab"]},{"year":2022,"claim":"Multiple studies cemented YEATS chromatin reading as the actionable core: cancer hotspot mutations form aberrant condensates, the YEATS domain is retained and essential in patient MLL-ENL leukemia, and YEATS inhibitors (TDI-11055) displace ENL to suppress oncogenic programs.","evidence":"Live-cell imaging/FRAP/ChIP-seq for condensates; mouse leukemia YEATS deletion/point mutants; ChIP-seq/RNA-seq/CRISPR-resistance/PDX for inhibitor","pmids":["36272410","36435883","36053276"],"confidence":"High","gaps":["Long-term resistance landscape to YEATS inhibition incomplete","Condensate role in non-mutant contexts less clear"]},{"year":2022,"claim":"Identifying KAT6A-deposited H3K9ac as the mark read by the ENL YEATS domain defined an upstream writer-reader module initiating elongation in AML.","evidence":"CRISPR differentiation screen, co-IP, ChIP-seq, KAT6A inhibition, YEATS binding assays","pmids":["34853079"],"confidence":"High","gaps":["Other acyltransferases feeding ENL not fully mapped","Promoter selectivity determinants unresolved"]},{"year":2024,"claim":"Later studies broadened ENL's chromatin biology: it governs super-enhancers via FACT recruitment and BRD4, reads the ketone-body mark H3K9bhb, and its ortholog's crotonylation-reader function modulates neuronal aging.","evidence":"AID depletion/ChIP-seq/FACT co-IP for SEs; chemical proteomics/CUT&Tag for H3K9bhb; Drosophila pan-neuronal RNAi with aging/oxidative readouts","pmids":["38241700","38880495","39405796"],"confidence":"High","gaps":["Mammalian neuronal/aging role of ENL untested","Interplay of distinct acyl marks at shared loci unresolved"]},{"year":2024,"claim":"Structural resolution of the multivalent ENL-MOZ assembly showed ENL's ET domain and YEATS domain together engage MOZ's IDR through CBP/p300-dependent acetylation, defining how an acyltransferase recruits ENL to active promoters.","evidence":"Structural studies, co-IP, ChIP-seq, domain mutagenesis, binding assays","pmids":["39794553"],"confidence":"High","gaps":["Functional consequence of ENL-MOZ coupling in disease not fully tested","Relationship to KAT6A module unclear"]},{"year":null,"claim":"How ENL integrates distinct acyl-mark inputs (H3K9ac, crotonyl, β-hydroxybutyryl) and switches between elongation-promoting condensates and PRC1-mediated repression to achieve gene- and context-specific outputs in normal physiology remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of mark-specific recruitment in normal cells","Physiological role of phase separation at endogenous loci unclear","Mammalian developmental/neuronal functions beyond embryonic lethality undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[4,9,17,18,19]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,8]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[5,6,12,25]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,3,4]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[8,17,26]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[5,8,22,26]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[5,17,19]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,9,23]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[7]}],"complexes":["AEP/EAP super elongation complex","PRC1 (via CBX8/BMI1)"],"partners":["AFF1/AF4","AFF4","DOT1L","CBX8","BMI1","KAT6A/MOZ","ABI1","CDK9"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q03111","full_name":"Protein ENL","aliases":["Eleven-nineteen-leukeumia","YEATS domain-containing protein 1"],"length_aa":559,"mass_kda":62.1,"function":"Chromatin reader component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA (PubMed:20159561, PubMed:20471948). Specifically recognizes and binds acetylated and crotonylated histones, with a preference for histones that are crotonylated (PubMed:27105114). Has a slightly higher affinity for binding histone H3 crotonylated at 'Lys-27' (H3K27cr) than 'Lys-20' (H3K9cr20) (PubMed:27105114). May play a role in leukemogenic gene transcription (PubMed:39794553) Acts as a key chromatin reader in acute myeloid leukemia by recognizing and binding to acetylated histones via its YEATS domain, thereby regulating oncogenic gene transcription","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q03111/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MLLT1","classification":"Not Classified","n_dependent_lines":30,"n_total_lines":1208,"dependency_fraction":0.024834437086092714},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MLLT1","total_profiled":1310},"omim":[{"mim_id":"618570","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 71; TRIM71","url":"https://www.omim.org/entry/618570"},{"mim_id":"614556","title":"AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1B; ARID1B","url":"https://www.omim.org/entry/614556"},{"mim_id":"613733","title":"MENIN 1; MEN1","url":"https://www.omim.org/entry/613733"},{"mim_id":"603024","title":"AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1A; ARID1A","url":"https://www.omim.org/entry/603024"},{"mim_id":"159557","title":"ALF TRANSCRIPTION ELONGATION FACTOR 1; AFF1","url":"https://www.omim.org/entry/159557"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli fibrillar center","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MLLT1"},"hgnc":{"alias_symbol":["ENL","LTG19","YEATS1"],"prev_symbol":[]},"alphafold":{"accession":"Q03111","domains":[{"cath_id":"2.60.40.1970","chopping":"7-144","consensus_level":"high","plddt":95.5464,"start":7,"end":144},{"cath_id":"1.20.80","chopping":"494-557","consensus_level":"high","plddt":90.128,"start":494,"end":557}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03111","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q03111-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q03111-F1-predicted_aligned_error_v6.png","plddt_mean":64.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MLLT1","jax_strain_url":"https://www.jax.org/strain/search?query=MLLT1"},"sequence":{"accession":"Q03111","fasta_url":"https://rest.uniprot.org/uniprotkb/Q03111.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q03111/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03111"}},"corpus_meta":[{"pmid":"9250666","id":"PMC_9250666","title":"Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9250666","citation_count":355,"is_preprint":false},{"pmid":"17855633","id":"PMC_17855633","title":"A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17855633","citation_count":331,"is_preprint":false},{"pmid":"20153263","id":"PMC_20153263","title":"A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.","date":"2010","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/20153263","citation_count":306,"is_preprint":false},{"pmid":"14701735","id":"PMC_14701735","title":"Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14701735","citation_count":273,"is_preprint":false},{"pmid":"28241139","id":"PMC_28241139","title":"Transcription control by the ENL YEATS domain in acute leukaemia.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28241139","citation_count":245,"is_preprint":false},{"pmid":"9418860","id":"PMC_9418860","title":"The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9418860","citation_count":207,"is_preprint":false},{"pmid":"8668146","id":"PMC_8668146","title":"TFG/TAF30/ANC1, a component of the yeast SWI/SNF complex that is similar to the leukemogenic proteins ENL and AF-9.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8668146","citation_count":143,"is_preprint":false},{"pmid":"25921070","id":"PMC_25921070","title":"Transcriptional elongation factor ENL phosphorylated by ATM recruits polycomb and switches off transcription for DSB repair.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25921070","citation_count":142,"is_preprint":false},{"pmid":"8134107","id":"PMC_8134107","title":"A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL.","date":"1994","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8134107","citation_count":118,"is_preprint":false},{"pmid":"8080983","id":"PMC_8080983","title":"ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells.","date":"1994","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8080983","citation_count":116,"is_preprint":false},{"pmid":"15856011","id":"PMC_15856011","title":"The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15856011","citation_count":101,"is_preprint":false},{"pmid":"8414510","id":"PMC_8414510","title":"MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13.","date":"1993","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8414510","citation_count":99,"is_preprint":false},{"pmid":"34853079","id":"PMC_34853079","title":"KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs.","date":"2022","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34853079","citation_count":86,"is_preprint":false},{"pmid":"10564558","id":"PMC_10564558","title":"Cytokine mRNA expression in leprosy: a possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL).","date":"1999","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10564558","citation_count":81,"is_preprint":false},{"pmid":"8378076","id":"PMC_8378076","title":"Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia.","date":"1993","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8378076","citation_count":80,"is_preprint":false},{"pmid":"26635203","id":"PMC_26635203","title":"MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26635203","citation_count":77,"is_preprint":false},{"pmid":"9486396","id":"PMC_9486396","title":"Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).","date":"1998","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9486396","citation_count":74,"is_preprint":false},{"pmid":"34079898","id":"PMC_34079898","title":"Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia.","date":"2021","source":"ACS central science","url":"https://pubmed.ncbi.nlm.nih.gov/34079898","citation_count":73,"is_preprint":false},{"pmid":"10458233","id":"PMC_10458233","title":"Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.","date":"1999","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/10458233","citation_count":73,"is_preprint":false},{"pmid":"36272410","id":"PMC_36272410","title":"Hotspot mutations in the structured ENL YEATS domain link aberrant transcriptional condensates and cancer.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/36272410","citation_count":68,"is_preprint":false},{"pmid":"20854876","id":"PMC_20854876","title":"MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.","date":"2010","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/20854876","citation_count":67,"is_preprint":false},{"pmid":"32270036","id":"PMC_32270036","title":"ENL initiates multivalent phase separation of the super elongation complex (SEC) in controlling rapid transcriptional activation.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32270036","citation_count":66,"is_preprint":false},{"pmid":"19584403","id":"PMC_19584403","title":"Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19584403","citation_count":65,"is_preprint":false},{"pmid":"28572162","id":"PMC_28572162","title":"CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo.","date":"2017","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/28572162","citation_count":63,"is_preprint":false},{"pmid":"16230385","id":"PMC_16230385","title":"Continuous MLL-ENL expression is necessary to establish a \"Hox Code\" and maintain immortalization of hematopoietic progenitor cells.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16230385","citation_count":57,"is_preprint":false},{"pmid":"11313972","id":"PMC_11313972","title":"The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11313972","citation_count":57,"is_preprint":false},{"pmid":"22516260","id":"PMC_22516260","title":"DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo.","date":"2012","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/22516260","citation_count":56,"is_preprint":false},{"pmid":"11522644","id":"PMC_11522644","title":"MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11522644","citation_count":53,"is_preprint":false},{"pmid":"18676843","id":"PMC_18676843","title":"Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18676843","citation_count":51,"is_preprint":false},{"pmid":"36053276","id":"PMC_36053276","title":"Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia.","date":"2022","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/36053276","citation_count":48,"is_preprint":false},{"pmid":"25456127","id":"PMC_25456127","title":"Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25456127","citation_count":47,"is_preprint":false},{"pmid":"30359161","id":"PMC_30359161","title":"Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.","date":"2018","source":"SLAS discovery : advancing life sciences R & D","url":"https://pubmed.ncbi.nlm.nih.gov/30359161","citation_count":44,"is_preprint":false},{"pmid":"12642866","id":"PMC_12642866","title":"The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12642866","citation_count":43,"is_preprint":false},{"pmid":"23623499","id":"PMC_23623499","title":"MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cells.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23623499","citation_count":43,"is_preprint":false},{"pmid":"27050521","id":"PMC_27050521","title":"Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27050521","citation_count":41,"is_preprint":false},{"pmid":"10516753","id":"PMC_10516753","title":"The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator.","date":"1999","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/10516753","citation_count":37,"is_preprint":false},{"pmid":"34174329","id":"PMC_34174329","title":"The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and Kidney Cancer.","date":"2021","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34174329","citation_count":36,"is_preprint":false},{"pmid":"34279931","id":"PMC_34279931","title":"Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34279931","citation_count":34,"is_preprint":false},{"pmid":"7602217","id":"PMC_7602217","title":"Clinical and histological discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP.","date":"1995","source":"International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association","url":"https://pubmed.ncbi.nlm.nih.gov/7602217","citation_count":34,"is_preprint":false},{"pmid":"22527432","id":"PMC_22527432","title":"Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity.","date":"2012","source":"Journal of drugs in dermatology : JDD","url":"https://pubmed.ncbi.nlm.nih.gov/22527432","citation_count":34,"is_preprint":false},{"pmid":"32176478","id":"PMC_32176478","title":"Cell-Based Ligand Discovery for the ENL YEATS Domain.","date":"2020","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/32176478","citation_count":31,"is_preprint":false},{"pmid":"30407816","id":"PMC_30407816","title":"Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL).","date":"2018","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30407816","citation_count":28,"is_preprint":false},{"pmid":"30258537","id":"PMC_30258537","title":"Peptidomimetics for Targeting Protein-Protein Interactions between DOT1L and MLL Oncofusion Proteins AF9 and ENL.","date":"2018","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/30258537","citation_count":26,"is_preprint":false},{"pmid":"10777208","id":"PMC_10777208","title":"ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10777208","citation_count":25,"is_preprint":false},{"pmid":"31405949","id":"PMC_31405949","title":"The efficiency of murine MLL-ENL-driven leukemia initiation changes with age and peaks during neonatal development.","date":"2019","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/31405949","citation_count":24,"is_preprint":false},{"pmid":"19029444","id":"PMC_19029444","title":"Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19029444","citation_count":24,"is_preprint":false},{"pmid":"34431785","id":"PMC_34431785","title":"HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34431785","citation_count":23,"is_preprint":false},{"pmid":"31857843","id":"PMC_31857843","title":"Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1.","date":"2019","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/31857843","citation_count":22,"is_preprint":false},{"pmid":"30066088","id":"PMC_30066088","title":"ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia.","date":"2018","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/30066088","citation_count":21,"is_preprint":false},{"pmid":"12367585","id":"PMC_12367585","title":"The leukemia-associated gene Mllt1/ENL: characterization of a murine homolog and demonstration of an essential role in embryonic development.","date":"2002","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12367585","citation_count":19,"is_preprint":false},{"pmid":"26164398","id":"PMC_26164398","title":"KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.","date":"2015","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26164398","citation_count":19,"is_preprint":false},{"pmid":"31723780","id":"PMC_31723780","title":"A Novel Inducible Mouse Model of MLL-ENL-driven Mixed-lineage Acute Leukemia.","date":"2018","source":"HemaSphere","url":"https://pubmed.ncbi.nlm.nih.gov/31723780","citation_count":18,"is_preprint":false},{"pmid":"16433901","id":"PMC_16433901","title":"Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited.","date":"2006","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16433901","citation_count":17,"is_preprint":false},{"pmid":"17906700","id":"PMC_17906700","title":"Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17906700","citation_count":17,"is_preprint":false},{"pmid":"33967269","id":"PMC_33967269","title":"Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia.","date":"2021","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/33967269","citation_count":16,"is_preprint":false},{"pmid":"29158770","id":"PMC_29158770","title":"Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?","date":"2017","source":"Nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/29158770","citation_count":16,"is_preprint":false},{"pmid":"35612819","id":"PMC_35612819","title":"Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENL.","date":"2022","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35612819","citation_count":15,"is_preprint":false},{"pmid":"37594575","id":"PMC_37594575","title":"miR-122-5p Promotes Peripheral and Central Nervous System Inflammation in a Mouse Model of Intracerebral Hemorrhage via Disruption of the MLLT1/PI3K/AKT Signaling.","date":"2023","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/37594575","citation_count":14,"is_preprint":false},{"pmid":"38241700","id":"PMC_38241700","title":"Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38241700","citation_count":13,"is_preprint":false},{"pmid":"12169632","id":"PMC_12169632","title":"MLL-ENL cooperates with SCF to transform primary avian multipotent cells.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12169632","citation_count":13,"is_preprint":false},{"pmid":"17145626","id":"PMC_17145626","title":"Analysis of acute leukemias with MLL/ENL fusion transcripts: identification of two novel breakpoints in ENL.","date":"2007","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17145626","citation_count":13,"is_preprint":false},{"pmid":"8690968","id":"PMC_8690968","title":"Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.","date":"1996","source":"International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association","url":"https://pubmed.ncbi.nlm.nih.gov/8690968","citation_count":13,"is_preprint":false},{"pmid":"38880495","id":"PMC_38880495","title":"ENL reads histone β-hydroxybutyrylation to modulate gene transcription.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/38880495","citation_count":12,"is_preprint":false},{"pmid":"28068328","id":"PMC_28068328","title":"MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/28068328","citation_count":12,"is_preprint":false},{"pmid":"16875930","id":"PMC_16875930","title":"Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion gene.","date":"2006","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/16875930","citation_count":12,"is_preprint":false},{"pmid":"8640717","id":"PMC_8640717","title":"MLL/ENL fusion in congenital acute lymphoblastic leukemia with a unique t(11;18;19).","date":"1996","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/8640717","citation_count":12,"is_preprint":false},{"pmid":"27310306","id":"PMC_27310306","title":"Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity.","date":"2016","source":"Nucleus (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/27310306","citation_count":11,"is_preprint":false},{"pmid":"36435883","id":"PMC_36435883","title":"The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia.","date":"2022","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/36435883","citation_count":11,"is_preprint":false},{"pmid":"20113834","id":"PMC_20113834","title":"Three-way translocation involving MLL, MLLT1, and a novel third partner, NRXN1, in a patient with acute lymphoblastic leukemia and t(2;19;11) (p12;p13.3;q23).","date":"2010","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20113834","citation_count":11,"is_preprint":false},{"pmid":"24336127","id":"PMC_24336127","title":"In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity.","date":"2013","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/24336127","citation_count":10,"is_preprint":false},{"pmid":"39009564","id":"PMC_39009564","title":"Single-cell multiomics reveals ENL mutation perturbs kidney developmental trajectory by rewiring gene regulatory landscape.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39009564","citation_count":9,"is_preprint":false},{"pmid":"8690967","id":"PMC_8690967","title":"Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.","date":"1996","source":"International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association","url":"https://pubmed.ncbi.nlm.nih.gov/8690967","citation_count":9,"is_preprint":false},{"pmid":"38056703","id":"PMC_38056703","title":"Genomic characterization of Mycobacterium lepromatosis from ENL patients from India.","date":"2023","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38056703","citation_count":8,"is_preprint":false},{"pmid":"36645983","id":"PMC_36645983","title":"Design, synthesis of novel benzimidazole derivatives as ENL inhibitors suppressing leukemia cells viability via downregulating the expression of MYC.","date":"2023","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36645983","citation_count":8,"is_preprint":false},{"pmid":"35029993","id":"PMC_35029993","title":"Spiroarborin, an ent-Clerodane Homodimer from Callicarpa arborea as an Inhibitor of the Eleven-Nineteen Leukemia (ENL) Protein by Targeting the YEATS Domain.","date":"2022","source":"Journal of natural products","url":"https://pubmed.ncbi.nlm.nih.gov/35029993","citation_count":8,"is_preprint":false},{"pmid":"35108652","id":"PMC_35108652","title":"SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/35108652","citation_count":7,"is_preprint":false},{"pmid":"9731482","id":"PMC_9731482","title":"Antisense oligodeoxyribonucleotide against the MLL-LTG19 chimeric transcript inhibits cell growth and induces apoptosis in cells of an infantile leukemia cell line carrying the t(11;19) chromosomal translocation.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9731482","citation_count":7,"is_preprint":false},{"pmid":"25282333","id":"PMC_25282333","title":"Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4.","date":"2014","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/25282333","citation_count":7,"is_preprint":false},{"pmid":"20513125","id":"PMC_20513125","title":"Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.","date":"2010","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/20513125","citation_count":7,"is_preprint":false},{"pmid":"32437911","id":"PMC_32437911","title":"Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.","date":"2020","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/32437911","citation_count":7,"is_preprint":false},{"pmid":"38628784","id":"PMC_38628784","title":"Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable In Vivo Studies: Discovery of TDI-11055.","date":"2024","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/38628784","citation_count":7,"is_preprint":false},{"pmid":"16479159","id":"PMC_16479159","title":"The mechanism of hematopoietic progenitor cell immortalization by MLL-ENL.","date":"2006","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/16479159","citation_count":7,"is_preprint":false},{"pmid":"9071029","id":"PMC_9071029","title":"Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.","date":"1996","source":"Revista do Instituto de Medicina Tropical de Sao Paulo","url":"https://pubmed.ncbi.nlm.nih.gov/9071029","citation_count":7,"is_preprint":false},{"pmid":"37295550","id":"PMC_37295550","title":"The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemia.","date":"2023","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/37295550","citation_count":6,"is_preprint":false},{"pmid":"36735043","id":"PMC_36735043","title":"Circvrk1 downregulation attenuates brain microvascular endothelial cell damage induced by oxygen-glucose deprivation through modulating the miR-150-5p/MLLT1 axis.","date":"2023","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/36735043","citation_count":6,"is_preprint":false},{"pmid":"33144337","id":"PMC_33144337","title":"Myeloid transformation by MLL-ENL depends strictly on C/EBP.","date":"2020","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/33144337","citation_count":6,"is_preprint":false},{"pmid":"39794553","id":"PMC_39794553","title":"A multivalent engagement of ENL with MOZ.","date":"2025","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/39794553","citation_count":5,"is_preprint":false},{"pmid":"21239865","id":"PMC_21239865","title":"A case of therapy-related acute lymphoblastic leukemia with t(11;19)(q23;p13.3) and MLL/MLLT1 gene rearrangement.","date":"2011","source":"The Korean journal of laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21239865","citation_count":5,"is_preprint":false},{"pmid":"37958457","id":"PMC_37958457","title":"Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37958457","citation_count":5,"is_preprint":false},{"pmid":"21953510","id":"PMC_21953510","title":"Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.","date":"2011","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/21953510","citation_count":5,"is_preprint":false},{"pmid":"21436736","id":"PMC_21436736","title":"Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia.","date":"2011","source":"Journal of pediatric hematology/oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21436736","citation_count":5,"is_preprint":false},{"pmid":"35763909","id":"PMC_35763909","title":"Down-regulation of MLLT1 super elongation complex subunit impairs the anti-tumor activity of natural killer cells in esophageal cancer.","date":"2022","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/35763909","citation_count":4,"is_preprint":false},{"pmid":"32766858","id":"PMC_32766858","title":"Exploitable metabolic dependencies in MLL-ENL-induced leukemia.","date":"2020","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/32766858","citation_count":4,"is_preprint":false},{"pmid":"34996478","id":"PMC_34996478","title":"Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene.","date":"2022","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/34996478","citation_count":4,"is_preprint":false},{"pmid":"39405796","id":"PMC_39405796","title":"The histone acylation reader ENL/AF9 regulates aging in Drosophila melanogaster.","date":"2024","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/39405796","citation_count":4,"is_preprint":false},{"pmid":"33127454","id":"PMC_33127454","title":"Long noncoding RNA MEG3 contributes to dysfunction of brain microvascular endothelial cells after intracerebral hemorrhage by regulating the miR-1930-5p/Mllt1 axis.","date":"2020","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/33127454","citation_count":4,"is_preprint":false},{"pmid":"25509985","id":"PMC_25509985","title":"An AF9/ENL-targted peptide with therapeutic potential in mixed lineage leukemias.","date":"2014","source":"Journal of experimental therapeutics & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25509985","citation_count":4,"is_preprint":false},{"pmid":"18347158","id":"PMC_18347158","title":"Preclinical modeling of cytosine arabinoside response in Mll-Enl translocator mouse leukemias.","date":"2008","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/18347158","citation_count":4,"is_preprint":false},{"pmid":"25481096","id":"PMC_25481096","title":"Identification of a novel isoform of the leukemia-associated MLLT1 (ENL/LTG19) protein.","date":"2014","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/25481096","citation_count":3,"is_preprint":false},{"pmid":"38829886","id":"PMC_38829886","title":"Myeloid Targeted Human MLL-ENL and MLL-AF9 Induces cdk9 and bcl2 Expression in Zebrafish Embryos.","date":"2024","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38829886","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47663,"output_tokens":7684,"usd":0.129125,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17255,"output_tokens":6091,"usd":0.119275,"stage2_stop_reason":"end_turn"},"total_usd":0.2484,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"ENL (MLLT1) is a nuclear protein with transcriptional transactivation activity in both lymphoid and myeloid cells, and in yeast. Deletion mutagenesis localized the minimal transcriptional activation domain to the C-terminal 90 amino acids of ENL, a region highly conserved with AF9 that is retained in all HRX-ENL and HRX-AF9 fusion proteins.\",\n      \"method\": \"Deletion mutagenesis, transient reporter gene assays in lymphoid and myeloid cell lines and yeast\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct mutagenesis with functional reporter assays, replicated across multiple cell types including yeast\",\n      \"pmids\": [\"8080983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity contributed by the C-terminal 84 amino acids of ENL (encoding two conserved helical structures). Deletions of either helix completely abrogated both transcriptional activation and in vitro myeloid transforming activity. The MLL methyltransferase homology domain was shown to bind DNA non-sequence specifically in vitro.\",\n      \"method\": \"Structure-function deletion analysis, in vitro myeloid immortalization assay, transcriptional reporter assays, in vitro DNA binding assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis coupled with both transformation and transcription assays; directly correlates ENL C-terminal domain function with leukemogenic activity\",\n      \"pmids\": [\"9418860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"HRX-ENL fusion protein directly immortalizes a myelomonocytic precursor and induces myeloid leukemia in mice. Wild-type ENL alone or HRX-ENL lacking the ENL component did not transform cells, establishing that the ENL moiety is required for the gain-of-function leukemogenic activity.\",\n      \"method\": \"Retroviral transduction of hematopoietic stem cells, serial replating colony assay, syngeneic and SCID mouse leukemia model\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — deletion mutant controls in both in vitro and in vivo transformation assays; replicated across multiple recipient mouse strains\",\n      \"pmids\": [\"9250666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The C-terminal domain of ENL (the same region required for transformation) directly recruits human Polycomb 3 (hPc3/CBX8) via a protein-protein interaction. This was demonstrated by yeast two-hybrid, GST pull-down, far-western blot, mutual co-immunoprecipitation from cell extracts, and co-localization of fluorescently tagged proteins in nuclear dot patterns in living cells.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, far-western blot, co-immunoprecipitation, live-cell fluorescence co-localization\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical methods (Y2H, pulldown, far-western, co-IP, live imaging) all confirming the same interaction\",\n      \"pmids\": [\"11313972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ENL directly interacts with AF4 and AF5q31 (and a fragment of AF10) through its C-terminus (also the transformation-essential domain). The ENL/AF4 interaction was confirmed by GST pull-down and mutual co-immunoprecipitation. Both proteins co-localized in nuclear speckles in vivo and co-eluted on sizing columns with Polycomb3, suggesting a multiprotein complex. The YEATS domain of ENL is essential for transcriptional activation from a reporter construct. ENL binds histones H3 and H1 in a YEATS domain-dependent manner.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, co-localization, size exclusion chromatography, histone overlay and pull-down assays, reporter assay with YEATS domain mutants\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods confirming interactions and YEATS domain function; YEATS-dependent histone binding established by overlay/pulldown with mutagenesis\",\n      \"pmids\": [\"15856011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ENL associates in vivo with a complex (EAP) containing pTEFb (CDK9/Cyclin T), DOT1L (histone H3K79 methyltransferase), AF4, AF5q31, LAF4, and Polycomb members (RING1, CBX8, BCoR). Purified EAP displayed H3K79-specific methylase activity and robust RNA Pol II CTD kinase function. ENL knockdown reduced genome-wide H3K79 dimethylation and global transcriptional elongation. DOT1L recruitment to ENL was important for transformation by MLL-ENL.\",\n      \"method\": \"Immunopurification + mass spectrometry, co-immunoprecipitation, yeast two-hybrid, GST pull-down, co-localization, in vitro histone methylase assay, RNA Pol II CTD kinase assay, global run-on elongation assay, shRNA knockdown\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (IP-MS, co-IP, in vitro enzymatic assays, knockdown phenotypes) in single study; mechanistically links ENL to elongation and H3K79 methylation\",\n      \"pmids\": [\"17855633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ENL and AF9 family proteins together with AF4 family proteins form a higher-order complex (AEP) containing P-TEFb. AEP is normally recruited to MLL-target chromatin to facilitate transcription, and MLL oncoproteins fused with AEP components constitutively form hybrid complexes causing sustained target gene expression and hematopoietic progenitor transformation.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), hematopoietic progenitor transformation assay\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP and ChIP establish complex formation and chromatin recruitment; transformation assays demonstrate functional consequence\",\n      \"pmids\": [\"20153263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In response to DNA double-strand breaks (DSBs), ENL is phosphorylated by ATM at conserved SQ sites. This phosphorylation increases ENL's interaction with PRC1 via BMI1, promoting enrichment of PRC1 at transcription elongation sites near DSBs, leading to H2A ubiquitination and transcriptional repression. ENL SQ sites and BMI1 are required for KU70 accumulation at DSBs near active transcription.\",\n      \"method\": \"Co-immunoprecipitation, phosphorylation assays, ChIP, siRNA knockdown, DSB survival assays, ATM kinase assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods establishing ATM-dependent phosphorylation of ENL and its functional consequence in transcriptional repression at DSBs\",\n      \"pmids\": [\"25921070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The YEATS chromatin-reader domain of ENL is essential for ENL-dependent leukaemic growth. Acute loss of ENL (via chemical genetic targeted degradation) suppressed initiation and elongation of RNA polymerase II at active genes genome-wide, with pronounced effects at genes with disproportionate ENL load. CRISPR loss-of-function screen identified ENL as specifically required for proliferation in MLL-AF4-positive leukemia in vitro and in vivo.\",\n      \"method\": \"CRISPR-Cas9 genome-scale loss-of-function screen, auxin-inducible degron targeted protein degradation, ChIP-seq, RNA Pol II elongation assays, YEATS domain point mutagenesis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genome-scale genetic screen combined with targeted protein degradation, functional mutagenesis of YEATS domain, and genome-wide mechanistic assays in single rigorous study\",\n      \"pmids\": [\"28241139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Recurrent gain-of-function mutations in the YEATS domain of MLLT1 (ENL) in Wilms tumours alter binding to acetylated histone tails. Mutant MLLT1 tumours show increased MYC expression and HOX dysregulation.\",\n      \"method\": \"Genomic sequencing of Wilms tumour samples, biochemical binding assays of mutant vs wild-type YEATS domain to acetylated histone tails, gene expression analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct biochemical demonstration of altered acetyl-histone binding by YEATS mutants; functional consequence inferred from gene expression; single study\",\n      \"pmids\": [\"26635203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cancer-associated hotspot mutations in the ENL YEATS domain trigger aberrant transcriptional condensates at native genomic targets. Mechanistically, mutation-induced structural changes in the YEATS domain, ENL's two disordered regions of opposing charges, and incorporation of extrinsic elongation factors are all required for condensate formation. Extensive mutagenesis establishes condensate formation as a driver of oncogenic gene activation.\",\n      \"method\": \"Fluorescence live-cell imaging, FRAP, mutagenesis, ChIP-seq, gene expression analysis, structural analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — extensive mutagenesis, live-cell imaging with FRAP, and ChIP-seq mechanistically link mutation-induced condensate formation to oncogenic transcription\",\n      \"pmids\": [\"36272410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ENL, or its intrinsically disordered region (IDR) alone, is sufficient to initiate liquid-liquid phase separation and liquid droplet formation of the super elongation complex (SEC). AFF4 cooperates with ENL in fluidizing SEC droplets. SEC droplets form rapidly upon serum exposure and are required for rapid transcriptional induction. MLL-ENL fusion boosts SEC phase separation compared to wild-type ENL.\",\n      \"method\": \"In vitro droplet formation assays, live-cell fluorescence imaging, FRAP, transcriptional reporter assays, IDR deletion/mutagenesis\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro reconstitution of phase separation, live-cell imaging with FRAP, and functional mutagenesis of IDR in single study\",\n      \"pmids\": [\"32270036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ENL serves as a scaffold that contacts the elongation machinery AND Polycomb repressive complex 1 (PRC1) component CBX8, but these interactions are mutually exclusive in vitro. CBX8 inhibits transcriptional elongation in a reporter assay, and this is neutralized by direct ENL-CBX8 association. CBX8-binding-defective MLL-ENL cannot fully activate leukemogenic gene loci. MLL-ENL also dimerizes as a neomorphic activity that may augment Polycomb inhibition.\",\n      \"method\": \"Biochemical co-immunoprecipitation, in vitro binding (mutual exclusivity), transcriptional reporter assay, mutagenesis, transformation assay in hematopoietic progenitors\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro mutual exclusivity of interactions established biochemically, corroborated by in vivo transformation assays with structure-function mutants\",\n      \"pmids\": [\"23623499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"ENL directly interacts with ABI1 (c-Abl interactor 1, itself fused to MLL in t(10;11) leukemia). Identified by yeast two-hybrid screen; verified by far-western blot, GST pull-down, and co-immunoprecipitation from cell extracts. Structure-function analysis identified an internal region of ENL and a composite SH3-containing motif of ABI1 as mutual binding partners.\",\n      \"method\": \"Yeast two-hybrid, far-western blot, GST pull-down, co-immunoprecipitation, deletion mapping\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical methods (Y2H, far-western, GST pulldown, co-IP) with domain mapping\",\n      \"pmids\": [\"10777208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Insertion of the third PHD finger of MLL into MLL-ENL allows recruitment of Cyp33 and subsequently HDAC1 to the fusion protein, mediates HOX gene downregulation in a Cyp33-dependent manner, and blocks hematopoietic stem cell immortalization by MLL-ENL. Loss of the PHD fingers in MLL fusion proteins is thus necessary for the constitutive transactivation that drives leukemogenesis.\",\n      \"method\": \"Co-immunoprecipitation, gene expression analysis (RT-PCR), serial replating colony assay (immortalization), domain insertion mutagenesis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain insertion mutagenesis with co-IP and functional immortalization assay; single laboratory study with clear mechanistic conclusion\",\n      \"pmids\": [\"18676843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A specific salt bridge formed by a pair of amino acids between MLLT1/ENL and AFF family proteins (AF4/AFF1) is critically important for MLL-ENL-mediated transformation of hematopoietic progenitor cells. Mutational disruption of this salt bridge abrogates transformation.\",\n      \"method\": \"Mutational analysis, hematopoietic progenitor cell transformation assay, structural modeling informed by MLLT3-AFF1 complex structure\",\n      \"journal\": \"Leukemia research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — structure-guided mutagenesis with functional transformation assay; single lab, informed by structural data from paralog\",\n      \"pmids\": [\"25282333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ENL YEATS domain displaces from chromatin upon treatment with the small-molecule inhibitor TDI-11055 (blocking acylated histone interaction), rapidly decreasing chromatin occupancy of ENL-associated complexes and impairing transcription elongation, leading to suppression of oncogenic gene programs and induction of differentiation. A CRISPR-Cas9 mutagenesis screen identified an ENL mutation conferring resistance, validating on-target chromatin displacement mechanism.\",\n      \"method\": \"ChIP-seq, RNA-seq, CRISPR resistance screen, patient-derived xenograft in vivo model, biochemical YEATS domain binding assay\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — on-target validation by resistance mutagenesis, genome-wide chromatin displacement shown by ChIP-seq, in vivo efficacy, multiple orthogonal methods\",\n      \"pmids\": [\"36053276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"KAT6A-catalyzed H3K9 acetylation at promoters is bound by the ENL YEATS domain, initiating a transcriptional control module in which ENL cooperates with a network of chromatin factors to induce transcriptional elongation. KAT6A inhibition phenocopies ENL loss in AML.\",\n      \"method\": \"CRISPR differentiation screen, co-immunoprecipitation, ChIP-seq, KAT6A inhibition, ENL YEATS domain binding assays\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR screen combined with co-IP, ChIP-seq, and biochemical YEATS-acetylH3K9 interaction established mechanistic writer-reader module\",\n      \"pmids\": [\"34853079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ENL YEATS domain binds histone H3K9β-hydroxybutyrylation (H3K9bhb), a new histone acyl mark. Chemical proteomics with multivalent photoaffinity probes identified ENL as a novel H3K9bhb reader. CUT&Tag confirmed co-localization of ENL with H3K9bhb at promoters. Structure-based mutation disrupting H3K9bhb-ENL interaction suppressed MYC-driven cell proliferation.\",\n      \"method\": \"Chemical proteomics (photoaffinity probes), biochemical binding assay, CUT&Tag chromatin profiling, structure-based mutagenesis, gene expression analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — chemical proteomics discovery confirmed by biochemical binding, chromatin localization, and functional structure-based mutagenesis in single study\",\n      \"pmids\": [\"38880495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ENL associates with the acetyltransferase MOZ through a multivalent assembly. The extraterminal (ET) domain of ENL recognizes the canonical ET-binding motif in the intrinsically disordered region (IDR) of MOZ. Additionally, the YEATS domain of ENL binds to acetylation sites within the MOZ IDR that are generated by CBP/p300 acetyltransferase activity. Genomic analysis showed ENL and MOZ co-occupy active promoters, and MOZ recruits ENL to its gene targets.\",\n      \"method\": \"Structural studies, co-immunoprecipitation, ChIP-seq, domain mutagenesis, biochemical binding assays\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — structural resolution of multivalent assembly combined with functional genomics and mutagenesis confirming acetylation-dependent and -independent ENL-MOZ coupling\",\n      \"pmids\": [\"39794553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"MLL-ENL-induced block of myelomonocytic cell differentiation requires the oncoprotein Myc. Co-transduction of dominant-negative Myc neutralized MLL-ENL transformation, while constitutive Myc expression cooperated with MLL-ENL to cause irreversible maturation arrest. G-CSF-mediated differentiation was accompanied by c-myc downregulation.\",\n      \"method\": \"Retroviral co-transduction, dominant-negative Myc expression, gene expression analysis, colony assay, differentiation assay with G-CSF\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis via dominant-negative and overexpression approaches in primary hematopoietic cells; single lab study\",\n      \"pmids\": [\"11522644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MLL-ENL activates Hoxa9, Hoxa7, Meis1, and Pbx3 expression as critical downstream targets. Enforced expression of Hoxa9 combined with Meis1 was sufficient to substitute for MLL-ENL function and maintain continuous proliferation and differentiation arrest. Overexpression of the Hox repressor Bmi-1 inhibited MLL-ENL growth-transforming activity.\",\n      \"method\": \"Inducible MLL-ENL-ERtm system, microarray analysis, retroviral overexpression, tamoxifen withdrawal differentiation assay, Bmi-1 overexpression epistasis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible system combined with target identification, epistasis (Bmi-1), and rescue (Hoxa9+Meis1) experiments establishing pathway hierarchy\",\n      \"pmids\": [\"14701735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MLL-ENL directly targets two functionally distinct gene groups: ME5 genes bound at promoters, dependent on DOT1L-mediated H3K79 methylation, encoding transcription factors including Hox genes; and ME3 genes with MLL-ENL accumulation beyond the termination site, dependent on P-TEFb-mediated RNA Pol II phosphorylation, encoding proteins in RNA biology and ribosome assembly. These groups show differential sensitivity to DOT1L and P-TEFb inhibitors.\",\n      \"method\": \"Nascent RNA-seq, ChIP-seq, small molecule inhibitor treatment (DOT1L and P-TEFb inhibitors), transformed cell line analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide nascent RNA and chromatin profiling combined with pharmacological inhibition distinguishing two mechanistically distinct MLL-ENL target gene classes\",\n      \"pmids\": [\"27050521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The YEATS domain within the MLL-ENL fusion protein is retained in 84.1% of MLL-ENL patient samples and is crucial for MLL-ENL-mediated leukemogenesis in mouse models. Deletion of the YEATS domain impaired MLL-ENL binding and decreased expression of pro-leukemic genes including Eya1 and Meis1. Point mutations disrupting YEATS domain binding to acetylated histones decreased leukemic stem cell frequency and increased leukemia latency.\",\n      \"method\": \"Retroviral mouse leukemia model, YEATS domain deletion and point mutagenesis, ChIP, gene expression analysis, limiting dilution transplantation for stem cell frequency\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain deletion and point mutagenesis with in vivo leukemia models and stem cell frequency assays; corroborated by patient sample analysis\",\n      \"pmids\": [\"36435883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SIRT2 deacetylase regulates MLL-ENL-driven AML. A conserved lysine K469 in the ENL linker region controls cell cycle progression and chemotherapy resistance; substitution with an acetylated mimic (K469Q) abolished MLL-ENL's ability to suppress proliferation and promote chemo-resistance. SIRT2 deletion promoted proliferation and sensitized MLL-ENL AML cells to chemotherapy.\",\n      \"method\": \"Murine MLL-ENL AML model, K469Q acetylation mimic mutagenesis, Sirt2 knockout, cell cycle analysis, chemotherapy sensitivity assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — acetylation mimic mutagenesis and Sirt2 KO with functional read-outs; single lab, focused on ENL linker region acetylation\",\n      \"pmids\": [\"35108652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The intrinsically disordered C-terminal ANC1 homology domain (AHD) of ENL/MLLT1 undergoes coupled binding and folding upon interaction with partner proteins including AF4, DOT1L, BCOR, and CBX8. NMR backbone dynamics studies of the complexes revealed dynamics-dependent function of the AHD.\",\n      \"method\": \"NMR spectroscopy, binding assays, structural analysis of AHD complexes\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR-based structural characterization; review article summarizing structural work, but reports direct NMR/structural findings; single consolidated description\",\n      \"pmids\": [\"34174329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ENL occupies the majority of super-enhancers (SEs) with higher preference over typical enhancers in a manner dependent on its ability to bind acetylated histones (YEATS domain). Rapid ENL depletion decommissions SEs, repressing SE-controlled oncogenes such as MYC. ENL interacts with the histone chaperone FACT complex and is required for FACT deposition over cis-regulatory elements; ENL's transcriptional control is regulated by BRD4.\",\n      \"method\": \"Auxin-inducible degron (AID) rapid depletion, ChIP-seq, FACT co-immunoprecipitation, ENL YEATS mutants, BRD4 inhibition, colorectal cancer in vivo model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rapid protein depletion with genome-wide ChIP-seq, co-IP for FACT interaction, and YEATS mutant studies establish SE regulation and FACT recruitment as direct ENL functions\",\n      \"pmids\": [\"38241700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Targeted disruption of murine Mllt1 leads to embryonic lethality prior to embryonic day 8.5, indicating an essential role for MLLT1 in early embryonic development.\",\n      \"method\": \"Gene targeting/knockout in mice, developmental phenotype analysis\",\n      \"journal\": \"Blood cells, molecules & diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with defined embryonic lethal phenotype; single study establishing developmental essentiality\",\n      \"pmids\": [\"12367585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In Drosophila, pan-neuronal knockdown of dENL/AF9 (the ENL/AF9 ortholog) extends lifespan and enhances fitness during aging, including improved sleep and locomotion. This is associated with upregulation of catalase, reduced malondialdehyde, and enhanced oxidative stress tolerance, revealing a role for the histone acylation (crotonylation) reader function of ENL/AF9 in neuronal aging.\",\n      \"method\": \"Pan-neuronal RNAi knockdown in Drosophila, lifespan analysis, locomotion assays, sleep analysis, oxidative stress assays, gene expression analysis\",\n      \"journal\": \"Neurobiology of aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo knockdown in Drosophila with multiple functional readouts; ortholog study with clear link to crotonylation reader function in aging\",\n      \"pmids\": [\"39405796\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MLLT1/ENL is a nuclear transcriptional coactivator containing an N-terminal YEATS domain that reads acetylated (and other acylated) histone lysines (particularly H3K9ac, H3K9cr, H3K9bhb) to recruit RNA Pol II elongation machinery, and a C-terminal intrinsically disordered ANC1 homology domain (AHD) that scaffolds a higher-order complex (AEP/SEC) with AF4 family proteins, P-TEFb, and DOT1L, driving transcriptional elongation and H3K79 methylation at target genes; upon DNA double-strand breaks, ENL is phosphorylated by ATM, switching its interaction from the elongation complex to PRC1 (via BMI1) to repress transcription near damage sites; gain-of-function YEATS mutations drive aberrant phase-separated condensates and oncogenic gene activation, while the MLL-ENL fusion constitutively recruits AEP to MLL target genes (Hoxa cluster, Meis1, Myc) to immortalize hematopoietic progenitors and cause leukemia.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MLLT1/ENL is a nuclear transcriptional coactivator that couples histone acylation recognition to RNA polymerase II elongation at active genes and super-enhancers [#8, #26]. Its N-terminal YEATS domain reads acetylated and other acylated histone lysines—including KAT6A/MOZ-deposited H3K9ac and the ketone-body mark H3K9β-hydroxybutyrylation—and this reader activity recruits ENL-associated complexes to chromatin to drive elongation [#17, #18, #19]. Through its C-terminal intrinsically disordered ANC1 homology domain (AHD), ENL scaffolds a higher-order elongation assembly (EAP/AEP/SEC) by coupled folding upon binding AF4-family proteins, P-TEFb (CDK9/Cyclin T), and the H3K79 methyltransferase DOT1L, and ENL is required for genome-wide H3K79 dimethylation and transcriptional elongation [#5, #6, #25]. The same domain alternatively engages PRC1 component CBX8, and these elongation- versus repression-directed interactions are mutually exclusive, allowing ENL to switch between activating and silencing outputs [#3, #12]. Following DNA double-strand breaks, ATM phosphorylates ENL at SQ sites, shifting it toward PRC1/BMI1 to promote local H2A ubiquitination and transcriptional repression near damage [#7]. ENL's intrinsically disordered regions drive liquid-liquid phase separation that fluidizes elongation-complex condensates required for rapid transcriptional induction [#11]. In disease, the MLL-ENL fusion constitutively recruits this elongation machinery to MLL targets (Hoxa cluster, Meis1, Myc) to immortalize hematopoietic progenitors and cause leukemia in a YEATS- and AF4-interaction-dependent manner [#2, #21, #23], and recurrent gain-of-function YEATS mutations in Wilms tumour generate aberrant transcriptional condensates that activate MYC and HOX programs [#9, #10]. ENL is genetically essential in MLL-rearranged leukemia and is a validated drug target via YEATS-domain inhibitors that displace it from chromatin [#8, #16].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing that ENL is itself a transcriptional activator was the first step toward explaining why its fusion partner matters in leukemia; this localized the activity to a conserved C-terminal domain shared with AF9.\",\n      \"evidence\": \"Deletion mutagenesis with transient reporter assays in lymphoid, myeloid, and yeast cells\",\n      \"pmids\": [\"8080983\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No molecular mechanism for activation identified\", \"No interacting partners defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that the ENL moiety is required for HRX-ENL leukemogenesis tied ENL's intrinsic transactivation function directly to oncogenic gain-of-function rather than mere fusion.\",\n      \"evidence\": \"Retroviral HSC transduction with serial replating and mouse leukemia models using deletion controls\",\n      \"pmids\": [\"9250666\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream target genes not identified\", \"Molecular partners of the ENL domain unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapping the transforming activity to two C-terminal helices showed that the same domain governs transcription and transformation, defining a single critical functional module.\",\n      \"evidence\": \"Structure-function deletion analysis with transformation and reporter assays plus in vitro DNA binding\",\n      \"pmids\": [\"9418860\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the proteins recruited by the helices\", \"Non-specific DNA binding role unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identifying ABI1 as a direct ENL partner connected ENL to another MLL fusion partner, hinting at a shared interaction network.\",\n      \"evidence\": \"Yeast two-hybrid, far-western, GST pull-down, co-IP with deletion mapping\",\n      \"pmids\": [\"10777208\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of ENL-ABI1 in transformation untested\", \"Region distinct from the transformation domain\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Two studies framed ENL as both a Polycomb-linked scaffold and a Myc-dependent transforming agent, foreshadowing its dual repressive/activating roles and downstream effectors.\",\n      \"evidence\": \"Co-IP/Y2H/far-western for CBX8 interaction; dominant-negative Myc and overexpression epistasis in primary hematopoietic cells\",\n      \"pmids\": [\"11313972\", \"11522644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a Polycomb-binding protein activates transcription unresolved\", \"Direct vs indirect role of Myc unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defining Hoxa9/Hoxa7/Meis1/Pbx3 as critical MLL-ENL targets and showing Hoxa9+Meis1 substitutes for the fusion established the downstream transcriptional program driving transformation.\",\n      \"evidence\": \"Inducible MLL-ENL-ER system with microarray, rescue, and Bmi-1 epistasis\",\n      \"pmids\": [\"14701735\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of target gene selection not defined\", \"How ENL sustains activation unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showing ENL binds AF4/AF5q31 through its transformation domain and binds histones via the YEATS domain unified the scaffolding and chromatin-reading functions into one model.\",\n      \"evidence\": \"Y2H, GST pull-down, co-IP, size exclusion, histone overlay/pulldown, YEATS mutant reporters\",\n      \"pmids\": [\"15856011\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific acyl marks read by YEATS not defined\", \"Composition of full complex incomplete\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Purifying the EAP complex containing P-TEFb and DOT1L, and showing ENL knockdown reduces global H3K79me2 and elongation, established ENL as a hub linking acylation reading to elongation and H3K79 methylation.\",\n      \"evidence\": \"IP-MS, co-IP, in vitro methylase/CTD kinase assays, run-on elongation, shRNA\",\n      \"pmids\": [\"17855633\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Recruitment cues to specific genes not defined\", \"Stoichiometry/architecture of complex unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating that re-inserting the MLL PHD finger recruits Cyp33/HDAC1 and blocks immortalization clarified that loss of repressive modules is what licenses constitutive MLL-ENL activation.\",\n      \"evidence\": \"Domain insertion mutagenesis, co-IP, RT-PCR, serial replating\",\n      \"pmids\": [\"18676843\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab domain-insertion model\", \"Generalizability across MLL fusions untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defining the AEP higher-order complex and its constitutive hijacking by MLL fusions formalized the mechanistic basis of sustained MLL-target expression and transformation.\",\n      \"evidence\": \"Reciprocal co-IP, ChIP, hematopoietic transformation assays\",\n      \"pmids\": [\"20153263\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of AEP assembly on chromatin not resolved\", \"Distinction from physiological recruitment unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showing ENL's elongation and CBX8/PRC1 contacts are mutually exclusive provided a molecular switch explaining how a single scaffold toggles between activation and Polycomb repression.\",\n      \"evidence\": \"Co-IP, in vitro mutual-exclusivity binding, reporter assays, transformation with structure-function mutants\",\n      \"pmids\": [\"23623499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger that selects between states in vivo unclear\", \"Role of MLL-ENL dimerization not fully resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Pinpointing a specific ENL-AFF1 salt bridge as essential for transformation provided an atomic-level target within the leukemogenic interaction.\",\n      \"evidence\": \"Structure-guided mutagenesis and hematopoietic transformation assay\",\n      \"pmids\": [\"25282333\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Modeled from paralog structure, not direct ENL structure\", \"Single-lab validation\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Two studies extended ENL beyond elongation: ATM phosphorylation switches it to PRC1/BMI1-mediated repression at DSBs, while recurrent Wilms tumour YEATS mutations alter acetyl-histone binding to dysregulate MYC/HOX.\",\n      \"evidence\": \"Co-IP/phospho/ChIP/ATM assays for DSB response; tumour sequencing and YEATS binding/expression assays for Wilms mutants\",\n      \"pmids\": [\"25921070\", \"26635203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Wilms mutants inferred from expression in single study\", \"How the DSB switch is reversed unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Resolving MLL-ENL targets into DOT1L-dependent promoter-bound (ME5) and P-TEFb-dependent readthrough (ME3) classes revealed mechanistically distinct gene programs with differential drug sensitivities.\",\n      \"evidence\": \"Nascent RNA-seq, ChIP-seq, and DOT1L/P-TEFb inhibitor treatment\",\n      \"pmids\": [\"27050521\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of class assignment unclear\", \"Applicability to wild-type ENL targets untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"A genome-scale CRISPR screen plus targeted degradation established ENL as a non-redundant, YEATS-dependent dependency controlling Pol II initiation and elongation in MLL-AF4 leukemia.\",\n      \"evidence\": \"CRISPR LOF screen, auxin-inducible degron, ChIP-seq, YEATS point mutants\",\n      \"pmids\": [\"28241139\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism distinguishing high-load genes unresolved\", \"Physiological (non-leukemic) requirement less defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that ENL's IDR drives phase separation of the SEC introduced condensate formation as the physical basis for rapid transcriptional induction and MLL-ENL enhancement.\",\n      \"evidence\": \"In vitro droplet assays, live-cell imaging, FRAP, IDR mutagenesis, reporters\",\n      \"pmids\": [\"32270036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous-level condensate relevance at native loci not fully shown\", \"Contribution to gene specificity unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Structural and regulatory studies refined ENL function: the AHD folds upon binding diverse partners, and SIRT2-controlled K469 acetylation in the linker modulates MLL-ENL proliferation and chemoresistance.\",\n      \"evidence\": \"NMR backbone dynamics of AHD complexes; K469Q mimic and Sirt2 KO in murine AML\",\n      \"pmids\": [\"34174329\", \"35108652\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"AHD findings consolidated/review-level\", \"SIRT2-ENL axis from single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Multiple studies cemented YEATS chromatin reading as the actionable core: cancer hotspot mutations form aberrant condensates, the YEATS domain is retained and essential in patient MLL-ENL leukemia, and YEATS inhibitors (TDI-11055) displace ENL to suppress oncogenic programs.\",\n      \"evidence\": \"Live-cell imaging/FRAP/ChIP-seq for condensates; mouse leukemia YEATS deletion/point mutants; ChIP-seq/RNA-seq/CRISPR-resistance/PDX for inhibitor\",\n      \"pmids\": [\"36272410\", \"36435883\", \"36053276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term resistance landscape to YEATS inhibition incomplete\", \"Condensate role in non-mutant contexts less clear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying KAT6A-deposited H3K9ac as the mark read by the ENL YEATS domain defined an upstream writer-reader module initiating elongation in AML.\",\n      \"evidence\": \"CRISPR differentiation screen, co-IP, ChIP-seq, KAT6A inhibition, YEATS binding assays\",\n      \"pmids\": [\"34853079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other acyltransferases feeding ENL not fully mapped\", \"Promoter selectivity determinants unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Later studies broadened ENL's chromatin biology: it governs super-enhancers via FACT recruitment and BRD4, reads the ketone-body mark H3K9bhb, and its ortholog's crotonylation-reader function modulates neuronal aging.\",\n      \"evidence\": \"AID depletion/ChIP-seq/FACT co-IP for SEs; chemical proteomics/CUT&Tag for H3K9bhb; Drosophila pan-neuronal RNAi with aging/oxidative readouts\",\n      \"pmids\": [\"38241700\", \"38880495\", \"39405796\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian neuronal/aging role of ENL untested\", \"Interplay of distinct acyl marks at shared loci unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Structural resolution of the multivalent ENL-MOZ assembly showed ENL's ET domain and YEATS domain together engage MOZ's IDR through CBP/p300-dependent acetylation, defining how an acyltransferase recruits ENL to active promoters.\",\n      \"evidence\": \"Structural studies, co-IP, ChIP-seq, domain mutagenesis, binding assays\",\n      \"pmids\": [\"39794553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of ENL-MOZ coupling in disease not fully tested\", \"Relationship to KAT6A module unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ENL integrates distinct acyl-mark inputs (H3K9ac, crotonyl, β-hydroxybutyryl) and switches between elongation-promoting condensates and PRC1-mediated repression to achieve gene- and context-specific outputs in normal physiology remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of mark-specific recruitment in normal cells\", \"Physiological role of phase separation at endogenous loci unclear\", \"Mammalian developmental/neuronal functions beyond embryonic lethality undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [4, 9, 17, 18, 19]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 8]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5, 6, 12, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 3, 4]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [8, 17, 26]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [5, 8, 22, 26]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [5, 17, 19]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 9, 23]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [\"AEP/EAP super elongation complex\", \"PRC1 (via CBX8/BMI1)\"],\n    \"partners\": [\"AFF1/AF4\", \"AFF4\", \"DOT1L\", \"CBX8\", \"BMI1\", \"KAT6A/MOZ\", \"ABI1\", \"CDK9\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":8,"faith_total":8,"faith_pct":100.0}}